Skip to main content

Famotidine

NDC 63323-738 · Fresenius Kabi USA, LLC

Generic nameFAMOTIDINE
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)FAMOTIDINE
Strength10 mg/mL
Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

63323-738-09 — 10 VIAL, MULTI-DOSE in 1 TRAY (63323-738-09) / 4 mL in 1 VIAL, MULTI-DOSE (63323-738-03)

63323-738-20 — 10 VIAL, MULTI-DOSE in 1 TRAY (63323-738-20) / 20 mL in 1 VIAL, MULTI-DOSE (63323-738-06)

Billed under HCPCS

J1308 — Injection, famotidine, 0.25 mg Medicare Part B payment limit (ASP + 6%): $0.01

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61442-121 — Famotidine, 61442-122 — Famotidine, 62135-807 — famotidine, 62135-808 — famotidine, 62332-001 — Famotidine, 62332-002 — Famotidine, 63187-129 — Famotidine, 63187-723 — Famotidine, 63187-908 — Famotidine, 63187-999 — Famotidine, 63323-739 — Famotidine, 63629-2014 — Famotidine, 63629-2015 — Famotidine, 63629-2782 — Famotidine, 63629-7013 — Famotidine, 63629-8891 — Ibuprofen and famotidine, 63868-583 — Famotidine, 63868-584 — Famotidine, 63941-009 — Famotidine, 63941-011 — Famotidine, +401 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources